CXCL12 and acute myeloid leukemia: Our findings support earlier studies suggesting that in AML, elevated levels of CXCR4-expressing microparticles and SDF-1, which correlate with higher white blood cell counts, play a significant role in disease progression and may serve as potential diagnostic markers (14).